Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma.

M J van Acht1, J Hermans, D E Boks

  • 1Department of Clinical Oncology, University Hospital Leiden, The Netherlands.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pregnancy following oocyte donation].

Nederlands tijdschrift voor geneeskunde·1997
Same author

Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival.

Cancer·1997
Same author

Stepwise compared with rapid application of vacuum in ventouse extraction procedures.

British journal of obstetrics and gynaecology·1997
Same author

Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene.

The Journal of clinical endocrinology and metabolism·1997
Same author

Accuracy of the Jamshidi trocar biopsy in the diagnosis of bone tumors.

Clinical orthopaedics and related research·1997
Same author

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation.

Blood·1996

Low hemoglobin levels in patients with head and neck cancer indicate a poorer response to radiation therapy. Hemoglobin (Hb) levels at the end of treatment are a significant prognostic factor for disease-free survival in glottic carcinoma.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Research

Background:

  • A link between low hemoglobin (Hb) content and poor radiation therapy response is known, particularly in squamous cell carcinomas.
  • The exact reasons, such as tumor hypoxia or other factors, remain unclear.
  • Small head and neck tumors offer a unique model to study Hb's prognostic importance by minimizing confounding variables.

Purpose of the Study:

  • To investigate the prognostic significance of hemoglobin levels in patients with glottic or supraglottic carcinoma.
  • To determine if Hb values correlate with other patient characteristics.

Main Methods:

  • Retrospective analysis of 306 patients with glottic or supraglottic carcinoma.
  • All patients received primary radiotherapy (60-70 Gy over 6-7 weeks).

Related Experiment Videos

  • Statistical analysis to assess the impact of Hb levels on disease-free survival.

    • Main Results:

    • In glottic carcinoma, lower Hb levels at the start and end of therapy correlated with worse disease-free survival (p=0.09, p=0.0012).
    • For supraglottic carcinoma, low Hb at the end of treatment predicted poorer survival (p=0.05).
    • A decrease in Hb of ≥0.5 mmol/l during treatment reduced disease-free survival in glottic cancer (p=0.0125).
    • Multivariate analysis identified end-of-treatment Hb as an independent prognostic factor, independent of tumor stage (T- and N-classification).
    • No association was found between Hb levels and nutritional status or Karnofsky Performance Scale.

    Conclusions:

    • Hemoglobin levels, particularly at the end of radiation therapy, are a significant independent prognostic factor for disease-free survival in glottic and supraglottic carcinomas.
    • Monitoring and potentially managing Hb levels during treatment may be crucial for improving outcomes in these cancer patients.